These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1567790)

  • 21. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
    Nikolić-Zugić J; Carbone FR
    Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactivity patterns of vaccinia-specific cytotoxic T lymphocytes from H-2Kb mutants.
    Hurwitz JL; Pan S; Wettstein PJ; Doherty PC
    Immunogenetics; 1983; 17(1):79-87. PubMed ID: 6600708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide specificity of alloreactive CD4 positive T lymphocytes directed against a major histocompatibility complex class I disparity.
    Ossevoort MA; De Bruijn ML; Van Veen KJ; Kast WM; Melief CJ
    Transplantation; 1996 Nov; 62(10):1485-91. PubMed ID: 8958276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
    Isakov N; Segal S
    Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of the alloreactive T cell repertoire: K region homology between H-2b T cell precursors and T cell maturation environment is required for the generation of the Kbm6-specific cytotoxic T cell repertoire.
    Gress RE; Hodes RJ
    J Immunol; 1984 May; 132(5):2226-31. PubMed ID: 6201535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).
    Smith PA; Brunmark A; Jackson MR; Potter TA
    J Exp Med; 1997 Mar; 185(6):1023-33. PubMed ID: 9091576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
    Heath WR; Hurd ME; Carbone FR; Sherman LA
    Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct demonstration of critical amino acid residues required for cytotoxic T-lymphocyte allorecognition of H-2 class I antigens.
    McLaughlin-Taylor E; Miyada CG; McMillan M; Wallace RB
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3085-9. PubMed ID: 2452442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies against an H-2Kb-specific cytotoxic T cell clone detect several clone-specific molecules.
    Hua C; Boyer C; Buferne M; Schmitt-Verhulst AM
    J Immunol; 1986 Mar; 136(6):1937-44. PubMed ID: 3485135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.
    Itoh T; Storkus WJ; Gorelik E; Lotze MT
    J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M; Pendleton CD; Berzofsky JA
    J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-reactivity patterns of influenza-specific cytotoxic T lymphocytes from H-2Kb mutant mice.
    Hurwitz JL; Wettstein PJ; Bennink JR; Doherty PC
    J Immunol; 1983 Jul; 131(1):471-4. PubMed ID: 6190923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA; Burke K; Koszinowski UH; Hansen TH; Connolly JM
    J Immunol; 1993 Jul; 151(1):1-10. PubMed ID: 8392095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes.
    Blake J; Johnston JV; Hellström KE; Marquardt H; Chen L
    J Exp Med; 1996 Jul; 184(1):121-30. PubMed ID: 8691125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.